The bacteriostatic water for injection market share is expected to increase to USD 2.28 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 6.6%.
The report extensively covers bacteriostatic water for injection market segmentations by the following:
- End-user - Hospitals, clinics, and others
- Geography - North America, Europe, Asia, and Rest of World (ROW)
The bacteriostatic water for injection market report offers information on several market vendors, including Abbott Laboratories, AdvaCare Pharma, B. Braun SE, CAPTAB BIOTEC UNIT II, Covetrus Inc., Daiichi Sankyo Co. Ltd., Fresenius SE and Co. KGaA, FUJIFILM Holdings Corp., GlaxoSmithKline Plc, Medefil Inc., Merck and Co. Inc., Merit Healthcare International Inc., Novartis AG, Pfizer Inc., Pharma Cure Laboratories, Sanofi, and SteriMax Inc. among others.
This bacteriostatic water for injection market research report provides valuable insights into the post-COVID-19 impact on the market, which will help companies evaluate their business approaches.
What will the Bacteriostatic Water for Injection Market Size be During the Forecast Period?
Download the Free Report Sample to Unlock the Bacteriostatic Water for Injection Market Size for the forecast Period and Other Important Statistics
Bacteriostatic Water for Injection Market: Key Drivers, Trends, and Challenges
The growth of the biopharmaceutical and generic injectable drugs industries is notably driving the bacteriostatic water for injection market growth, although factors such as side effects associated with benzyl alcohol may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the bacteriostatic water for the injection industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Bacteriostatic Water for Injection Market Driver
- The growth of the biopharmaceutical and generic injectable drugs industries is one of the key drivers fueling the bacteriostatic water for injection market growth.
- The biotechnology and pharmaceutical companies that are primarily involved in the discovery and development of drugs to treat prevalent and new diseases are increasingly identifying drug targets.
- Pharmaceutical companies are also discovering and developing new medicines owing to the increasing prevalence of chronic diseases globally.
- Significantly, the development of generic injectable drugs is a rapid process when compared to branded ones, as pharmaceutical companies are exempted from the requirement to conduct toxicity studies and clinical trials for generic injectable drugs.
- A large number of vendors are entering the global generic injectable drugs industry to offer cost-effective alternatives to branded products, which has led to increased adoption of generic products.
Therefore, the demand for bacteriostatic water for injection is expected to increase in line with the growth of the global biopharmaceutical and generic injectable drugs industries during the forecast period.
Key Bacteriostatic Water for Injection Market Trend
- The development of new drugs and vaccines for COVID-19 is one of the key bacteriostatic water for injection market trends supporting the market growth.
- Various drugs and vaccines can be used for the treatment of COVID-19, which are in several stages of clinical trials. These drugs include injectable drugs that need to be diluted, dissolved, and administered through intravenous, subcutaneous, and intramuscular routes.
- In April 2020, the United States Food and Drug Administration (US FDA) launched the COVID-19 Treatment Acceleration Program (CTAP) to authorize new treatments and conduct trials for potential drugs to treat COVID-19.
- In September 2021, the Pan American Health Organization (PAHO) announced the selection of two centres in Argentina and Brazil as regional hubs for developing and producing messenger ribonucleic acid (mRNA)-based COVID-19 vaccines.
Therefore, the increase in the development of new drugs and vaccines for COVID-19 will drive the growth of the global bacteriostatic water for injection market during the forecast period.
Key Bacteriostatic Water for Injection Market Challenge
- Side effects associated with benzyl alcohol are one of the factors challenging the bacteriostatic water for injection market growth.
- Benzyl alcohol-containing formulations cannot be used for neonatal medications due to the potential toxicity of benzyl alcohol in neonates. They should be used for neonates only if there are no possible alternatives.
- Benzyl alcohol is more likely to develop toxicity in premature and low-birth-weight neonates. These formulations cannot be given for more than a week in the case of children under three years of age unless necessary.
- The administration of an estimated 9 ml of benzyl alcohol-containing formulations to a 6 kg infant or a neonate can potentially cause blood pressure changes in the infant.
Thus, the various side effects associated with benzyl alcohol-containing bacteriostatic water can hamper the growth of the global bacteriostatic water for injection market during the forecast period.
This bacteriostatic water for injection market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Who are the Major Bacteriostatic Water for Injection Market Vendors?
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
- Abbott Laboratories
- AdvaCare Pharma
- B. Braun SE
- CAPTAB BIOTEC UNIT II
- Covetrus Inc.
- Daiichi Sankyo Co. Ltd.
- Fresenius SE and Co. KGaA
- FUJIFILM Holdings Corp.
- GlaxoSmithKline Plc
- Medefil Inc.
- Merck and Co. Inc.
- Merit Healthcare International Inc.
- Novartis AG
- Pfizer Inc.
- Pharma Cure Laboratories
- Sanofi
- SteriMax Inc.
This statistical study of the bacteriostatic water for injection market encompasses successful business strategies deployed by the key vendors. The bacteriostatic water for injection market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.
Product Insights and News
- Abbott.com - The company offers bacteriostatic water for injection namely Similac Water.
- Bbraun.com - The company offers bacteriostatic water for injection which is a diluent or solvent suitable for intravascular injection after first having been made approximately isotonic by the addition of a suitable solute.
- Gsk.com - The company offers bacteriostatic water for injection such as Nucala which is an interleukin 5 antagonist monoclonal antibody.
To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The bacteriostatic water for injection market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Which are the Key Regions for the Bacteriostatic Water for Injection Market?
for more insights on the market share of various regions Request a FREE sample now!
39% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for bacteriostatic water for injection in North America. Market growth in this region will be faster than the growth of the market in the Rest of World (ROW).
The increasing expenditure and per capita spending on pharmaceutical drugs will facilitate the bacteriostatic water for injection market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
In 2020, the COVID-19 pandemic had a positive impact on the regional bacteriostatic water injection market. For instance, the National Institutes of Health (NIH), the medical research agency of the US, received approximately $4.9 billion in grants to fund important COVID-19 research activities on COVID-19 vaccines and treatments. Thus, the increased support received from regional governments will contribute to the growth of the bacteriostatic water for injection market during the forecast period.
What are the Revenue-generating End-user Segments in the Bacteriostatic Water for Injection Market?
To gain further insights on the market contribution of various segments Request a FREE sample
The bacteriostatic water for injection market share growth by the hospital's segment will be significant during the forecast period. Patients largely depend on end-users such as hospitals that provide a wide range of medical services and conduct surgical and non-surgical procedures for various disorders. Large hospitals such as tier 1 and tier 2 hospitals with 300-1,000 beds, including multispecialty hospitals, diagnose and monitor most of the surgical events conducted in outpatient settings. Growing partnerships between hospitals and clinics, the presence of multispecialty hospitals, the emergence of aesthetic clinics, and medical tourism will boost the growth of the segment, which, in turn, will drive the growth of the global bacteriostatic water for injection market during the forecast period.
This report provides an accurate prediction of the contribution of all the segments to the growth of the bacteriostatic water for injection market size and actionable market insights on the post-COVID-19 impact on each segment.
Parent Market Analysis
Technavio categorizes the global bacteriostatic water for injection market as a part of the global healthcare supplies market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the bacteriostatic water for injection market during the forecast period.
Bacteriostatic Water for Injection Market Value Chain Analysis
Our report provides extensive information on the value chain analysis for the bacteriostatic water injection market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
|
Bacteriostatic Water for Injection Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2021 |
|
forecast period |
2022-2026 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 6.6% |
|
Market growth 2022-2026 |
$ 2.28 billion |
|
Market structure |
Fragmented |
|
YoY growth (%) |
6.0 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 39% |
|
Key consumer countries |
US, Canada, Germany, the UK, and China |
|
Competitive landscape |
Leading companies, Competitive Strategies, Consumer engagement scope |
|
Key companies profiled |
Abbott Laboratories, AdvaCare Pharma, B. Braun SE, CAPTAB BIOTEC UNIT II, Covetrus Inc., Daiichi Sankyo Co. Ltd., Fresenius SE and Co. KGaA, FUJIFILM Holdings Corp., GlaxoSmithKline Plc, Medefil Inc., Merck and Co. Inc., Merit Healthcare International Inc., Novartis AG, Pfizer Inc., Pharma Cure Laboratories, Sanofi, and SteriMax Inc. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
What are the Key Data Covered in this Bacteriostatic Water for Injection Market Report?
- CAGR of the market during the forecast period 2022-2026
- Detailed information on factors that will drive bacteriostatic water for injection market growth during the next five years
- Precise estimation of the bacteriostatic water for injection market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behaviour
- The growth of the bacteriostatic water for injection industry across North America, Europe, Asia, and Rest of World (ROW)
- A thorough analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of bacteriostatic water for injection market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch